-Producing Lung Lymphocytes in
Mouse Silicosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
Abstract |
|---|
|
|
|---|
Silicosis is characterized by mononuclear cell inflammation with macrophage activation, accumulation of
lymphocytes, and fibrosis. Interferon-
(IFN-
) is a lymphocyte cytokine with broad effects, particularly
macrophage activation. Mice exposed to an aerosol of cristobalite silica (70 mg/m3, 12 d, 5 h/d) developed
diffuse pulmonary pathologic changes with macrophage, lymphocyte, and neutrophil recruitment, and increased lung collagen. IFN-
messenger RNA (mRNA) was more abundant by semiquantitative reverse
transcription-polymerase chain reaction in the lungs of silica-exposed mice than in control animals. IFN-
mRNA transcripts were detected by in situ hybridization with digoxigenin-labeled complementary DNA
probes in normal mouse lung tissue within bronchial-associated lymphoid tissues (BALT). In silica-
exposed mice, mononuclear cells with IFN-
mRNA were more numerous in the silicotic lesions and enlarged BALT structures. Lung-cell suspensions were prepared by enzyme digestion, stained with fluorescent-labeled antibodies against intracellular cytokines, and enumerated by flow cytometry. The percentage
of cells producing IFN-
was increased in silicotic mice (19% versus 11%). Interleukin (IL)-4 mRNA transcripts were less abundant in the lung tissue from silica-exposed mice than in control mice. Cells staining
for IL-4 mRNA were found rarely in either the air-sham or the silica-exposed mouse lungs, and almost all
appeared to be within BALT structures. Approximately 3% of cells stained for IL-4 in the digested lungs
from both groups. Similar cytokine patterns were observed in mediastinal lymph node/thymus and spleen
tissues. The augmented IFN-
response, with IL-4 unchanged or decreased, in the lung lesions and lymphoid tissue of mice with silicosis suggests a Th-1-like lymphocyte-mediated immune-inflammatory response.
| |
Introduction |
|---|
|
|
|---|
Silicosis is a chronic diffuse parenchymal lung disease that results from exposure for prolonged periods to airborne respirable dust containing crystalline silica particles. Although industrial hygiene measures to control ambient dust in the workplace have reduced its prevalence and severity, silicosis remains a prevalent health problem in developing nations throughout the world. In addition to its importance as an occupational lung disease, silicosis may serve as a paradigm for mechanisms of lung injury, inflammation, and fibrosis.
Silicosis in humans is characterized by nodules of mononuclear cell inflammation at sites of mineral particle accumulation, with progression of localized and ultimately diffuse fibrosis. The pulmonary macrophage is believed to be the key initial responder cell that ingests silica and consequently becomes activated to produce a variety of cytokines and other mediators that may augment tissue injury, promote neutrophil and lymphocyte accumulation, and stimulate fibroblast proliferation with altered connective tissue matrix deposition (1, 2). Although direct interactions between silica and pulmonary macrophages are undoubtedly important, most macrophages in the lungs of humans, rats, or mice exposed to silica do not contain particles (3, 4). This observation suggests a reiterative amplification cycle in which macrophages with silica produce cytokines that attract and activate lymphocytes, and suggests that these lymphocytes then produce additional mediators that attract and activate an expanded secondary population of macrophages. The goal of our current research was to identify mediators that might serve as mechanisms for macrophage recruitment and activation.
Lymphocytes accumulate in lung tissue, in bronchoalveolar lavage fluid (BALF), within intrapulmonary lymphoid aggregates and bronchial-associated lymphoid tissue (BALT), and in enlarged draining lymph nodes of both humans and animals with silicosis. These lymphocytes are mostly T cells, with relatively greater enrichment of CD4+ than CD8+ phenotypes, although both are increased (5). The T cells appear to be activated, express the interleukin (IL)-2 receptor, and show enhanced spontaneous DNA synthesis (10). Preliminary studies with intratracheal silica instillation reported that mice genetically deficient in mature T-cell responses (Balb/c nu/nu) evidenced less macrophage and lymphocyte inflammation than their T cell-sufficient counterparts, but comparable pulmonary fibrosis (11).
A subset of naive CD4+ T cells (Th-0) differentiates
upon activation into at least two major functional phenotypes, Th-1 cells or Th-2 cells (12). Differentiation is
driven predominantly toward one or the other subset by
local influences. These two subsets are polarized opposites, and each mutually suppresses the other. They are
recognized by their functional characteristics and by the
cytokines they produce, rather than by unique surface antigens. The Th-1 subset dominates macrophage activation,
granuloma formation, and delayed-type hypersensitivity,
and is a primary response to infectious intracellular pathogens such as Listeria. It is induced by interferon-
(IFN-
)
and IL-12, is suppressed by IL-4, and produces primarily
IL-2, IL-3, granulocyte macrophage colony-stimulating factor, tumor necrosis factor (TNF), and IFN-
. The Th-2 subset is abundant in allergic responses and helminthic infections, promotes immunoglobulin (Ig)E and IgG1 antibody
responses, and is induced by IL-4, is suppressed by IFN-
,
and produces IL-4, IL-5, IL-10, and IL-2. The cytokines
IFN-
and IL-4 may serve as markers, respectively, for the
Th-1 and Th-2 subsets. These functional profiles suggest
that a Th-1-like population of lymphocytes might be expected in silicosis.
IFN-
is a lymphocyte cytokine with broad biologic effects. It is produced by lymphocytes, particularly by natural killer cells and by subsets of CD4+ and CD8+ T cells
(15). Its effects on target cells are mediated through a
dimeric membrane receptor with the assistance of a third
protein. IFN-
is recognized as the most important cytokine
in converting macrophages from a resting to an activated
state. IFN-
augments expression of major histocompatibility complex Class II molecules both on macrophages
and on other cell types. IFN-
also appears to augment
TNF-
production by macrophages subjected to a second stimulus, and to synergize many of the effects of TNF-
. In
contrast to the proinflammatory effects of IFN-
noted
previously, administration of the cytokine may diminish
allograft rejection, reduce the severity of autoimmune nephritis, downregulate selected macrophage cytokines, and
possibly diminish skin fibrosis (18, 19).
IL-4 is a peptide produced by activated T cells and mast cells that modulates immune responses, growth, and differentiation in a variety of target cell types, including B cells, monocytes, and fibroblasts (20). It is a key mediator in promoting asthma and allergic responses in the respiratory tract (23, 24). IL-4 appears to have an important effect in promoting fibrosis. IL-4 added to cell cultures stimulated collagen synthesis in normal and scleroderma human skin fibroblasts, and in fibroblasts from other organs (25). The effect of IL-4 appears to be on gene transcription, mediated by activation of the procollagen gene promotors (28). Human and murine fibroblast subpopulations demonstrate differing collagen synthesis responsiveness to IL-4 based on the abundance or heterogeneity of the IL-4 receptor.
Lung-tissue sections from patients with idiopathic pulmonary fibrosis demonstrated substantially increased numbers of cells expressing IL-4 messenger RNA (mRNA)
(31). Skin biopsy specimens and skin fibroblasts from scleroderma patients demonstrated IL-4 mRNA and IL-4 protein, whereas normal skin materials rarely showed evidence for this cytokine (32). In the liver, anti-IL-4 antibody treatment decreased hepatic fibrosis in Schistosoma-infected
mice. In experimental radiation pneumonitis in the rat, IL-4
mRNA expression, soluble IL-4 protein, and cells stained
in situ for IL-4 were all increased (33). In mice with bleomycin-induced lung injury, lymphocyte IFN-
production
was increased and IL-4 production decreased, but anti-CD3 antibody reduced IL-4 further and decreased pulmonary fibrosis (34). Intratracheal instillation of silica into
mice resulted in a prompt increase of IL-10 protein in lung tissue and BALF cells; IL-10-deficient genetically modified mice demonstrated a greater inflammatory response
immediately after silica instillation, but slightly reduced
pulmonary fibrosis at 30 d (35). These observations suggest that IFN-
and IL-4 have counterbalancing and/or
synergistic effects on granulomatous inflammation and on fibrosis.
We reported recently on the features of silicosis in mice
exposed by inhalation to an aerosol of cristobalite silica
(36). These animals developed diffuse pulmonary pathologic changes consistent with silicosis in rodents; demonstrated an expanded airspace population of cells enriched
for macrophages, lymphocytes, and neutrophils; and showed
increased lung hydroxyproline content as a reflection of
increased lung collagen. We observed overexpression of
both IL-1
and TNF-
genes in the lungs of mice with silicosis, evidenced by increased mRNA extracted from whole-lung tissue and by localization of message by in situ hybridization in macrophages within pathologic lesions (37).
These two macrophage-derived cytokines, particularly IL-1
, would be candidates for inclusion in the mechanisms
by which lymphocytes are mobilized and activated in silicosis (6, 38).
We undertook the present research to determine lymphocyte cytokine production patterns in silicosis. We hypothesized that the lymphocyte response profile in silicosis
would follow a Th-1-like pattern, and that IFN-
production would be increased. We developed this hypothesis because the pathology of silicosis bears features of a granulomatous response, and thus a Th-1 lymphocyte subset would be a likely participant, and because IFN-
would be
a likely candidate for augmenting the previously identified
macrophage activation state that is characteristic of silicosis. Alternative hypotheses could be developed regarding
the production of IL-4. A Th-1-like lymphocyte response
with abundant IFN-
might be expected to suppress IL-4
production and the Th-2 lymphocyte subset. Conversely, the presence of pulmonary fibrosis as a part of silicosis
could be the result, in part, of increased IL-4. To test these
hypotheses, we examined the abundance of IFN-
and
IL-4 mRNA transcripts, cells expressing message in situ,
and the relative numbers of isolated lung cells producing cytokines.
| |
Materials and Methods |
|---|
|
|
|---|
Animals and Silica Exposure
The methods for exposure of mice to silica by inhalation of aerosol have been reported in detail (36). Mice (Mus musculus) of the strain C3H/HeN were obtained at 5 to 6 wk of age through the National Institutes of Health (Washington, DC), supplied by Harlan Sprague-Dawley (Indianapolis, IN). Aerosol exposure to cristobalite silica (C&E Minerals, King of Prussia, PA) was carried out using a horizontal-flow inhalation toxicology system (36, 49). The mice were divided into air-sham control or silica-exposed groups, and were exposed to the HEPA-filtered, humidified, temperature-controlled carrier airstream or to the mineral dust in identical chambers for 5 h/d for 12 d. The mice were exposed in two separate experiments to ambient cristobalite concentrations of 70 ± 19 or 70 ± 11 mg/m3 (mean ± SD).
Tissues were collected for extraction of mRNA, and for
histology and in situ hybridization, 2 and 16 to 18 wk after
the completion of the 12-d silica or air-sham exposure, and
cells were isolated for flow cytometry studies 16 to 20 wk
after exposure. In addition to the lung tissues, we collected
materials from two other lymphoid organs. The mediastinal lymph nodes and thymus were harvested as a source of
mRNA likely to contain substantial IL-4 and IFN-
transcripts and thus serve as a "positive control" for detecting expression of these genes. Mononuclear cells were isolated
from the spleen as a source of lymphocytes that would be
expected to include cells producing IFN-
and IL-4. The
abundance of IFN-
and IL-4 in these organs was also compared between air-sham control and silica-exposed mice.
We have reported the results of total lung silica content, histopathology, lung collagen (hydroxyproline), and
BALF cell recovery from C3H/HeN mice under identical
exposure conditions in a previous publication (36). Our
methods for preparation of molecular probes and extraction of nucleic acids have been described (37). Mice were
killed by intraperitoneal injection of an overdose of sodium pentobarbital. For extraction of nucleic acids, the
thorax was opened, the mediastinal lymph nodes and
the adjacent (usually inseparable) thymus gland were removed, and the lobes of the right and left lungs were cut
away at the hilum. The tissues were plunged immediately
into liquid nitrogen, and were stored frozen at
90°C for
future analysis. For histopathology, the neck was incised, the trachea was cannulated with a polyethylene catheter,
the abdomen and thorax were opened, and the lungs were
exposed. The lungs were reinflated by gentle injection of
4% phosphate-buffered formalin fixative through the airway catheter until they reached approximately normal anatomic volume. Cubes of lung tissue were removed after several minutes fixation in situ, gently agitated in the fixative at room temperature for 24 h, and then washed and
stored in 70% ethanol fixative. Tissue was embedded in
paraffin, sectioned, and stained for histology with hematoxylin and eosin (H&E) or prepared for in situ hybridization.
Molecular Methods
Nucleic acids were isolated from frozen mouse tissues using Trizol Reagent (GIBCO BRL Life Technologies,
Grand Island, NY) (52). Complimentary DNA (cDNA)
probes were prepared to detect mRNA encoding the ubiquitous enzyme glyceraldehyde-3-phosphate dehydrogenase
(GAPDH), and the cytokines IFN-
and IL-4. Twenty-base primer pairs were designed from published gene sequences
to encompass approximately 450 to 500 exon base pairs
(bp), spanning introns when possible. The primer pairs
(and calculated strand lengths) were:
GAPDH-5' = CGG ATT TGG CCG TAT TGG GC; 3' = TGA TGG CAT GCA CTG TGG TC (518 bp).
IFN-
-5' = GCA TCT TGG CTT TGC AGC TC; 3' = CGA CTC CTT TTC CGC TTC CT (445 bp).
IL-4-5' = TCG TCA CTG ACG GCA GAG AG; 3' = CGA GTA ATC CAT TTG CAT GA (446 bp).
Primer oligonucleotides were synthesized by the Molecular Diagnostic Laboratory (Department of Pathology,
University of Vermont College of Medicine, Burlington,
VT) (GAPDH) or by Genosys Biotechnologies, Inc. (The
Woodlands, TX) (IFN-
and IL-4). Total RNA isolated from C3H/HeN mouse lymphoid tissue was used to generate cDNA first-strand products from mRNA by reverse
transcription (RT) using standard techniques (53). The
cDNA probes were generated with the first-strand cDNA
products and the specific primer pairs for each gene of interest using heat-stable DNA polymerase (TAQ; GIBCO
BRL) and repeated thermal cycling. The purified RT-
polymerase chain reaction (PCR) cDNA probes were
linked with biotin through a photokinetic reaction with
ultraviolet (UV) light (Rad-Free; Schleicher & Schuell,
Keene, NH), and were used for Northern analysis and for
semiquantitative PCR analysis to estimate the abundance
of the genes of interest in various tissues. For in situ hybridization, the cDNA probes were tagged for colorimetric detection by internal labeling with digoxigenin-linked
uridine triphosphate during PCR cycling (Boehringer Mannheim, Indianapolis, IN).
Semiquantitative RT-PCR was used to measure expression of the genes of interest in mouse lung tissue. Similar amounts of total RNA from air-sham control and silica-exposed lung tissues were subjected simultaneously to
RT. The first-strand product from each tissue was then serially diluted and subjected to PCR expansion with each
primer pair. Aliquots (1 µL) of the PCR products from each serial dilution were dotted onto a nylon membrane
(Nytran; Schleicher & Schuell), cross-linked with UV light
exposure, and subjected to hybridization with the biotinylated cDNA probes using the Rad-Free system (Schleicher
& Schuell). The membranes were then blocked with casein
reagent, reacted with streptavidin-alkaline phosphatase,
and washed. The membranes were placed against chemiluminescent phosphate substrate sheets with Biomax MR
film (Kodak, Rochester, NY), and the optical density of
each reaction dot was determined with a flat-bed scanner
(ES-1200C; Epson America Inc., Torrance, CA) using a
computer analysis system (Macintosh Power PC 7500, Apple Computer, Cupertino, CA; Photoshop 3.0, Adobe Systems, Inc., Mountain View, CA; and ScanAnalysis 2.55, Biosoft, Cambridge, UK). The optical density measurements for IFN-
and IL-4 samples were adjusted for the
ratio of GAPDH in control and silica samples: (Sample
gene optical density [OD]/Average OD of all samples) divided by (Sample GAPDH OD/Average GAPDH OD of
all samples). The adjustment provided by the GAPDH
comparison was less than 40% in all instances. The primer
pairs generated PCR products of the appropriate sizes (see
Figure 1) for the designated genes. The sensitivity and
specificity of the cDNA probes were demonstrated by
Northern blot analysis, digestion of hybridization targets
with ribonuclease (RNase) but not deoxyribonuclease
(DNase), and failure to interact with irrelevant targets.
|
In Situ Hybridization
Formalin-fixed, paraffin-embedded tissues were subjected to in situ hybridization using modifications of techniques described by Davis and associates (37) and Fleming and colleagues (54). The tissues were subjected to gentle digestion with protease type VIII (Sigma Chemical Co., St. Louis, MO) to improve penetration of probes, denatured with formamide, hybridized with the digoxigenin-labeled probes, reacted with alkaline-phosphatase-linked anti-digoxigenin antibody (Boehringer Mannheim), and reacted with a substrate solution of nitro blue tetrazolium and bromo-chloro-indoyl phosphate. The sections were examined microscopically for localization of the blue-black reaction product. Appropriate controls for each cDNA probe were created by omitting probe or protease digestion, by using irrelevant human tissues with the murine probes, or by digesting the tissues with RNase A (Sigma) or DNase (Sigma) prior to hybridization.
Lung and Spleen Cell Isolation
Lung mononuclear cells were isolated by collagenase enzyme digestion and gentle mechanical disruption using modifications of published techniques (7, 57). Mice were killed with an overdose of sodium pentobarbital, the trachea was cannulated, the thorax opened, and the lungs reinflated with a solution of collagenase Type I (324 U/ml; Sigma), bovine pancreatic Dnase I (75 U/ml; Sigma), and porcine heparin (25 U/ml; Elkins-Sinn, Inc., Cherry Hill, NJ) in Dulbecco's phosphate-buffered saline (PBS) with Mg2+ and Ca2+ (GIBCO BRL, Life Technologies). The aorta and the inferior vena cava were cut, and the lungs were perfused with this enzyme solution via the right ventricle until white. The lobes of the lungs were excised, sliced into small cubes, and agitated in 30 ml of the enzyme solution for 1 h at 37°C. Lungs from two mice were pooled for digestion. At 30 and 60 min the tissue suspension was gently aspirated and expelled from a syringe through a 14-g blunt cannula to assist tissue disruption, and finally passed through a nylon mesh strainer (Falcon Plastics, Franklin Lakes, NJ) to exclude large fragments. The isolated cell suspension was centrifuged at 225 × g for 10 min at 5°C, resuspended in RPMI 1640 medium with 5% fetal calf serum and with penicillin 100 U/ml and streptomycin 100 µg/ ml (RPMI/FCS/P-S) (Life Technologies), counted by visual hemocytometer, and aliquoted for flow cytometry staining.
Spleen cell suspensions were prepared by pressing the spleen between the frosted ends of glass microscope slides to disrupt the tissue by gentle shearing pressure, and were rinsed into RPMI/FCS. A pool of spleen cells from two mice was mixed, the larger debris was allowed to settle for 5 min at 5°C, the supernatant cell suspension was removed and centrifuged at 225 × g for 10 min at 5°C, the cell pellet was resuspended in 1 to 2 ml of RPMI/FCS, and the leukocyte cell number was counted by hemocytometer.
The lung cells or splenocytes were cultured with brefeldin A to block the secretion of cytokines and allow these peptides to accumulate in the cells for staining. Brefeldin A is a nontoxic inhibitor of intracellular transport that serves to disaggregate the Golgi apparatus (61, 62). For each flow cytometry sample, an aliquot of 1 × 106 spleen cells was placed in a 22-mm-diameter culture plate well (Corning/Costar, Cambridge, MA) with 1.0 ml of RPMI/ FCS/P-S. Brefeldin A (Sigma) was prepared as a 100× stock solution in ethanol and added at a final concentration of 10 µg/ml. The cells were cultured for 4 h at 37°C in a 5% CO2 environment, the plates were struck sharply to dislodge loosely adherent cells, the cell suspension was aspirated into 12 × 75-mm polystyrene tubes, and the plates were rinsed with additional medium. The cell suspension was centrifuged at 225 × g for 5 min at 5°C to pellet the cells for staining.
Intracellular Cytokine Staining
Staining for intracellular cytokines was performed using
modifications of published methods (62). The cell pellet in each tube was resuspended in 100 µl of RPMI/FCS
with rat polyclonal IgG (Zymed, San Francisco, CA) at 50 µg/ml, incubated for 10 min in the dark at 5°C, and centrifuged, and the supernate was discarded. Fixation, permeabilization, and staining were performed at room temperature. The cell pellet was resuspended in 50 µl of PBS, 100 µl of fixation medium was added (Fix & Perm, Reagent A;
Caltag, Burlingame, CA), and the pellet was incubated for
15 min. The mixture was diluted with 2.0 ml of PBS, and
the cells were pelleted by centrifugation at 350 × g for 5 min. The fixed cell pellet was suspended in 100 µl of PBS/
A with polyclonal rat IgG at 50 µg/ml, incubated for 10 min, diluted with 2.0 ml of PBS, and centrifuged. The pellet was mixed with 100 µl of saponin permeabilization solution (Fix & Perm, Reagent B; Caltag); 20 µl of antibody
against IFN-
or IL-4 (both rat-IgG1-
labeled with r-phycoerithrin or fluorescein isothiocyanate; Pharmingen, San
Diego, CA); or the isotype control was added, and the
sample was incubated for 15 min in the dark. The suspension was diluted with 2.0 ml of PBS, centrifuged, resuspended in 350 µl of 1% paraformaldehyde (EMS, Ft.
Washington, PA) in PBS, and held at 5°C for up to 24 h
until analysis by flow cytometry.
Cytofluorograph Analysis
The cell samples were examined in a dual laser four-color
Coulter EPICS Elite cytofluorograph (Miami, FL) using
Coulter Elite analysis software, evaluating 40,000 or more
cells per sample. Each sample population was classified for
cell size (forward scatter) and complexity (side scatter),
and a gate of interest was drawn around the viable small
mononuclear cell population, excluding debris and erythrocytes. Each cell within this gate was categorized for fluorescence intensity in the color channel relevant for the cytokine antibody fluorochrome. The results were expressed
as the percentage of cells within the size/complexity gate
of interest that stained positively for each marker after
subtracting the percent positive cells in the isotype control.
The specificity of intracellular cytokine staining was demonstrated by negative results or by decreased percentages
of stained cells when brefeldin A was omitted, the saponin
permeabilization step was omitted, or the cells were stained
with unlabeled antibody before staining with fluorochrome-linked antibody (data not shown). A cultured Th-2 CD4+
T-cell clone (courtesy of Karen Roessner, Department of
Medicine, University of Vermont) in which approximately
30% of the cells produced intracellular IL-4 staining was
used as a positive control for this cytokine. Differences between exposure groups were tested for significance (
= 0.05) by Student's t test (Systat 7.0; SPSS Inc., Chicago, IL).
| |
Results |
|---|
|
|
|---|
Silicosis in Mice
We reported previously the features of mice exposed to
aerosolized cristobalite at 70 mg/m3 for 5 h/d for 12 d (36).
We selected an early time point with few or no histopathologic changes (2 wk) and a late time point with obvious silicosis (16 to 20 wk) at which to examine IFN-
and IL-4
production. Two weeks after silica exposure, the lung tissues appeared normal or showed slight accumulation of
neutrophils and macrophages in the alveolar spaces; increased connective tissue matrix or widening of the alveolar septae was not apparent. At the same time, BALF cell
samples showed increased macrophages, lymphocytes, and
polymorphonuclear leukocytes with a twofold increase in
the total number of cells recovered, and lung collagen (hydroxyproline) was increased slightly but significantly in silica-exposed mice. At 16 wk after cristobalite aerosol exposure, the mice showed the pathology of silicosis in rodents:
focal parenchymal lesions, air spaces filled with cells and
exudate, increased cellularity, and interstitial thickening.
Increased lymphoid tissue was a prominent feature in the
lungs from silica-exposed mice, with enlarged and more
numerous BALT, and with parenchymal and subpleural
lymphoid aggregates. At 16 to 20 wk, lung collagen was increased to 155% of control levels, and BALF cell recovery
was increased more than threefold. The number of lymphocytes recovered by BAL from air-sham control mice
was 9.21 ± 6.83 × 104 (mean ± SD; 6.1% of total) compared with 33.48 ± 17.15 × 104 (7.5% of total) from silica-exposed mice. Thus, the inflammatory-cell response and
the accumulation of excess connective tissue matrix began
within 2 wk and continued through 16 to 20 wk after silica exposure.
Expression of IFN-
and IL-4
We assessed the production of IFN-
and IL-4 in mouse
lungs and in the mediastinal lymph nodes/thymus indirectly by measuring the abundance of steady-state mRNA
transcripts for these two genes of interest. The purpose of
these experiments was to determine whether the steady-state expression of these genes was altered in the lung or
in nearby lymphoid organs in silicosis. Semiquantitative RT-PCR products for GAPDH, IFN-
, and IL-4 were detected in mediastinal lymph node/thymic tissue and in lung
tissue from both air-sham and silica-exposed mice. GAPDH
was abundant in all tissues, whereas the cytokines were detected only when relatively high numbers of thermal cycles
were employed. Estimation of the abundance of mRNA
for IFN-
and IL-4 was based on selective enrichment in
comparable amounts of total RNA.
The total RNA recovered per lung from control mice was greater at 16 wk (240 µg) than at 2 wk (183 µg). We hypothesize that this change reflects an increase in size due to normal lung growth, and parallels the increases in body weight (23.6 to 41.9 g) and wet lung weight (150.2 to 168.5 mg) over the same time period. Total RNA recovery averaged 294 and 309 µg per lung at 2 and 16 wk in the silica-exposed mice, respectively, with similar increases in lung wet weight (182.4 and 212.5 mg, respectively). The body weights of air- and silica-exposed mice were not significantly different at 2 or at 16 wk. The lung wet weights of the silica-exposed mice were significantly greater than control mice at both 2 and 16 wk (P < 0.005). The increases in total RNA and wet lung weight in the mice with silicosis are believed to be due to the greater numbers of inflammatory cells, other lung cells, connective tissue matrix, and edema in these tissues.
IFN-
mRNA was more abundant in the lung tissues of
mice exposed to silica than in air-sham control animals at
both 2 and 16 wk after exposure. Figure 1 shows agarose
gel electrophoresis of RT-PCR products from air-sham
and silica-exposed mice 16 wk after exposure, demonstrating comparable abundance of GAPDH mRNA, but detection of IFN-
mRNA in silica-exposed lung tissue at a dilution at which little or no message was detected in control tissues. Samples from two or three individual mice or from
pools of two to four mice at each time point were examined by semiquantitative limiting-dilution RT-PCR analysis. The amounts of cytokine gene products were adjusted
for the proportion of GAPDH products in control versus
silica-exposed tissues. As shown in Figure 2A, IFN-
mRNA
transcripts were detected in silica-exposed lung tissue at
three times the abundance of control levels 2 wk after exposure, and at twice control levels at 16 wk after exposure.
The expression of IFN-
was increased in the intrathoracic
lymphoid tissue at 2 wk (202%) and at 16 wk (119%) in silica-exposed compared with air-sham tissue, as shown in
Figure 2B.
|
In contrast to the increase in IFN-
gene expression,
IL-4 mRNA transcripts were less abundant in the lung tissue from silica-exposed mice compared with the air-sham
controls. Figure 3A illustrates the results of semiquantitative RT-PCR analysis, showing that IL-4 mRNA was
slightly reduced at 2 wk (90% control) and substantially reduced at 16 wk (52% control) in the lungs from silica-
exposed mice. In the control lung tissue, the mRNA transcripts for both IFN-
and IL-4 were apparently somewhat
more abundant at 16 wk than at 2 wk when adjusted for
comparable expression of GAPDH. The abundance of IL-4
message was also decreased in the mediastinal lymph node/
thymus tissue of silica-exposed mice, with a slight reduction at 2 wk (81% control) and a very large reduction (3% control) by 16 wk after exposure, as shown in Figure 3B.
|
Localization of Cytokine Production in Tissues
Sites of IFN-
and IL-4 production in the lung were determined by in situ hybridization of the digoxigenin-labeled
cDNA probes with cytokine mRNA transcripts. The purpose of these experiments was to determine the anatomic
sites in the lung where production of these cytokines occurred in normal mice, and whether the same or different
sites were involved in silicosis. Cells containing substantial blue-black reaction product in the cytoplasm and nucleus stood out against pale gray background tissues, as
shown in Figure 4. The staining was eliminated when the
tissues were treated with RNase before in situ hybridization, whereas staining was not altered by pretreatment
with DNase. As previously reported (37), the digoxigenin-labeled GAPDH cDNA probe generated abundant reaction product in almost all nucleated cells in the alveolar
walls, bronchial mucosa, or lymphoid tissues.
|
IFN-
mRNA transcripts were detected in the BALT
structures in normal mouse lung tissue by in situ hybridization, as shown in Figure 4b. The cells with reaction product appeared to be small mononuclear cells consistent with
the morphology of lymphocytes. IFN-
mRNA-stained
cells were very rarely found among the alveolar structures
and bronchial walls of the control mice.
Small mononuclear cells with IFN-
mRNA reaction
product were found in the silicotic lesions of the lungs
from silica-exposed mice, as shown in Figure 4c. The positive cells appeared to be mixed among larger macrophages,
other cells, and debris. IFN-
-stained cells were also found
in the enlarged BALT structures and in the parenchymal
lymphoid aggregates of the silicotic mice. IFN-
-stained cells appeared to be much more numerous in the lung tissues from the exposed mice. In part, this may have been
because the BALT were larger and more frequently found,
and the silicotic lesions and parenchymal lymphoid aggregates were not seen in the normal tissue.
Cells staining with reaction product for IL-4 mRNA were
found rarely in either the air-sham or the silica-exposed
mouse lungs. Almost all of the IL-4-stained cells appeared
to be small mononuclear cells within BALT structures, as
illustrated in Figure 4d. Very rare, isolated cells with apparent staining were found in the lung parenchyma. Cells
with staining for IL-4 were notably less frequent than cells
staining for IFN-
in all of the tissues examined.
The Fraction of Cells Producing Cytokines
Cells containing intracellular cytokines were identified by
staining with flourescent-labeled antibodies against IFN-
or IL-4 and enumerated by flow cytometry. The purpose
of these experiments was to determine the proportion of
cells producing the cytokines among the mononuclear cell
population of the normal lung, and to assess whether the
proportions changed in silicosis. The flow cytometry approach was selected to provide information about the production of immunoreactive protein to complement the
mRNA expression data offered by our other methods, and
to provide a quantitative analysis enumerating thousands
of events. Cell suspensions from the lung were prepared
by enzyme digestion and gentle disruption, and from the
spleen by mechanical disruption. Small mononuclear cells
with the size (forward scatter) and complexity (side scatter) characteristics of lymphocytes were gated as an area
of interest in the cytofluorograph diagram, as shown in
Figure 5. Intracellular staining for IFN-
or IL-4 was defined by cell fluorescence above the background level generated by a similarly labeled irrelevant immunoglobulin of
the same species and isotype as the antibody. Staining for
IFN-
was readily identified as a second peak of positive
cells brighter than the majority of cells within the gate of
interest; a larger peak was evident in samples from silica-exposed mice compared with the air-sham controls. These
features are illustrated in Figure 5. Cells staining for IL-4
represented a smaller proportion of the total population,
but were evident as a bright subset (Figure 5). The small
mononuclear cells within the defined gate of interest produced both the greatest proportion of positive cells and
the clearest definition of bimodal peaks compared with regions outside of this gate. A very small proportion of cells
(0.2 to 0.5%) stained positively for both IFN-
and IL-4
when dual antibody staining with two fluorochromes was
used on the same specimen. The flow cytometry diagrams
shown in Figure 5 are representative of a typical experiment in which the lung digest cells and the spleen cells from two air-sham control mice or two silica-exposed mice
20 wk after exposure were pooled for analysis. Similar results were obtained from the multiple repetitions with
mice 16 to 20 wk after exposure that were used to develop
the methods. The numerical data and statistical analysis
(Figure 6) were generated by merging the results of two to
five replicates from each pooled specimen and from two
separate inhalation-exposure experiments.
|
|
The percentages of small mononuclear cells producing
IFN-
were significantly increased in both the lungs and
the spleens of mice with silicosis compared with the air-sham control animals, as shown in Figure 6A. In the lung
digest samples from control mice, an average of 11.3 ± 1.9% (mean ± SD) of lymphocytes stained positively for
intracellular IFN-
; whereas 19.3 ± 6.0% of cells were
positive in silica-exposed mice (P < 0.03). Splenocytes
were positive at 4.0 ± 0.7% and 6.3 ± 1.0%, respectively
(P < 0.01). Approximately 3% of cells stained positively
for IL-4 in both the lung and spleen cell samples from control and silica-exposed mice, with no significant differences between them (Figure 6B).
The number of cells recovered from the lungs of mice
exposed to silica was significantly increased compared
with the lungs of control mice (84 ± 20 × 105 cells/mouse,
versus 49 ± 14 × 105 cells/mouse, P < 0.01). The cytofluorograph gate of interest encompassed approximately 65%
of the total cell population, with no consistent differences
between exposure groups. Thus, the total number of IFN-
-
producing cells would have averaged about 10 × 105 in a
silica-exposed mouse lung, and 3.6 × 105 in an air-sham
control mouse, an approximately 3-fold increase in this cell
population. The absolute number of cells in the lung producing IL-4 would also have increased from approximately
0.38 × 105 in control mice to 1.63 × 105 in silica-exposed
mice. The number of cells recovered from the spleens of
silica-exposed mice was increased slightly but not significantly (158 ± 95 versus 133 ± 50 × 105 cells/mouse).
| |
Discussion |
|---|
|
|
|---|
We have found evidence for increased expression of IFN-
mRNA, increased numbers of cells expressing this gene,
and increased numbers of cells with intracellular immunoreactive IFN-
protein in the lungs of mice with silicosis
as compared with air-sham control mice. The cells responsible for the IFN-
production had the morphologic features of lymphocytes; were located mainly in the BALT
structures, lymphoid aggregates, and infiltrates in the lung;
and were intermingled with other cell types within the silicotic lesions of the lung. The detailed phenotypic features
of the cells producing IFN-
are under investigation but
were not the subject of the present research.
Limitations Imposed by the Methods
The apparent increase in IFN-
in the lungs of mice with
silicosis was found using three independent methods, suggesting that the central observation is robust. Nonetheless,
each approach has limitations that must be considered. Increased abundance of mRNA encoding for IFN-
was observed by semiquantitative PCR analysis of tissue extracts.
This technique is very sensitive but does not indicate in
which cells, or where within the organ, the message originated. Furthermore, post-transcriptional regulation of gene function could result in upregulation of mRNA without
ultimate increases in mature secreted cytokine peptides.
The quantitation of cytokine gene expression was based on
the assumption that expression of the constitutive enzyme
GAPDH did not increase, and the results could be modified if GAPDH was upregulated in parallel with IFN-
. This did not appear to be the case because similar amounts
of total RNA from control and silica-exposed tissues yielded
comparable expression of GAPDH. Changes in the rates of
mRNA transcription or degradation could not be estimated because only steady-state mRNA levels were measured. This approach could not distinguish between a large
number of cells producing small amounts of relevant mRNA
as opposed to a small number of cells producing abundant copies.
The technique of in situ hybridization was used to localize cytokine message expression in tissue sections. This
method is limited by the relative insensitivity of the technique, and it is likely that only cells expressing the gene of
interest at a high level are detected. The localization of reaction product depends on the conditions of the method.
Excessive development in the color substrate solution
could lead to diffuse nonspecific staining, whereas inadequate tissue digestion, hybridization, or color development could miss genuine reaction sites. The intensity of
staining varies somewhat across a large tissue section, and regions with excessive or absent reaction product must be
avoided. As a strength, in situ hybridization permits confirmation that cells expressing the gene of interest appear
in locations where it would be expected. The cells expressing IFN-
or IL-4 appeared to be small mononuclear cells
predominantly located in lymphoid organs, findings consistent with the expectation that lymphocytes are primarily
responsible for producing these cytokines. Conversely, GAPDH expression was detected in virtually all nucleated
cells but not in erythrocytes, consistent with the ubiquitous
distribution of this enzyme. It is likely that in situ hybridization for cytokine gene expression mainly detects cells
with abundant mRNA copies, and thus might miss cells
producing the cytokine from small numbers of transcripts.
Flow cytometry to identify cells producing cytokines
had the advantages that an antibody was used to detect
immunoreactive peptide rather than mRNA, and that automation permitted counting thousands of events with a
high level of precision. The sensitivity of the technique for
identifying cells producing cytokines is not known, and cells
with low levels might be missed. The disadvantages of this
method include the preparation of lung cells by digestion and the need to culture the cells before staining them. It is possible that the digestion process selected a subset of
cells enriched with or depleted of the cytokine of interest;
for example, cells producing IFN-
might be liberated or
might survive preferentially in comparison with cells producing IL-4. Similarly, digestion might alter gene expression in a manner that would change cytokine production.
The culturing of digested cells for 4 h with brefeldin A
could alter cytokine production so that it did not reflect
accurately the behavior of the same cell in the lung or
spleen. Our methods of analysis categorized cells as either
positive or negative for the production of cytokines, and
may have been insensitive to slight changes in the production of these peptides by the population as a whole. This
approach seemed justified because of the bimodal peaks
seen in the flow cytometry histograms (Figure 5).
Our previous findings demonstrated substantial enlargement of BALT and the appearance of parenchymal
lymphoid aggregates. Because these lymphocyte-rich foci
would be likely sources for the cytokines of interest, we
chose methods we believed would be successful in sampling these sites: isolation of lung cells from all sites by enzyme digestion of the whole lung, in situ hybridization in
whole lung sections, and extraction of mRNA from the
whole lung. BAL samples the free cells and fluids of the
bronchial and alveolar air spaces of the lung. We chose not
to examine lavage specimens in detail, because the BAL
results could represent a biased sample. Preliminary studies with BALF cell populations did show increased percentages of cells producing IFN-
in mice with silicosis
(data not shown).
Cytokines in the Normal Lung
The production of both IFN-
and IL-4 was detected by all
three methods in the lungs of normal air-sham control
mice. On the basis of the abundance of mRNA, the number of cells found by in situ hybridization, and the percentage of cells identified by flow cytometry, it appeared that
IFN-
was produced in somewhat greater amounts than
IL-4. It is possible that the steady-state levels of both message and peptide could be a false reflection of biologic activity or rapid turnover, and that the detection methods
might differ in sensitivity. In control lung tissues the abundance of mRNA transcripts for IFN-
and IL-4 both appeared to increase relative to GAPDH at 16 wk compared
with 2 wk. This difference may be due to more intense expression of these genes as the mice mature. It is possible as
well that cytokine mRNA and GAPDH mRNA are differentially susceptible to degradation during extraction, and
that unintended slight differences in handling of tissues at
2 and 16 wk led to the differences in control cytokine/ GAPDH mRNA ratios at these time points. Because control and exposed tissues were handled simultaneously and
identically at each time point, the possibility of differential
degradation would not explain the differences observed
between the air-sham control and the silica-exposed mice.
The cells producing both IFN-
and IL-4 appeared to
be lymphocytes on the basis of their size and complexity
characteristics identified by flow cytometry, and on the
basis of their morphology by in situ hybridization. The
mRNA-positive cells in the normal lung appeared to be almost exclusively located within defined lymphoid aggregates and BALT. These findings suggest that lymphocytes with Th-1- and with Th-2-like features are part of the
lymphoid constituency of the normal lung. Production of
IFN-
and IL-4 was also identified in the lymphoid organs
of the thorax (mediastinal lymph nodes and thymus) and
in the spleens of the air-sham control mice, as would be expected. These tissues were included in our experiments to
serve as positive sources of cells producing the cytokines
of interest.
Increased Production of IFN-
in Silicosis
The production of IFN-
was increased in the lungs of
mice with silicosis compared with air-sham controls when
assessed by all three of the methods used. The abundance
of IFN-
mRNA transcripts was increased both at an early
time point after exposure (2 wk) and at a later time point
after obvious pathologic silicosis had developed (16 wk).
Because the lung tissue was not distinctly abnormal and
the number of lymphocytes was only slightly increased at
2 wk, we focused attention at 16 to 20 wk for flow cytometry and in situ hybridization. By flow, the percentage of
cells producing IFN-
was increased by 70% and the approximate number of cells in the lung was increased threefold. Many of these cells were localized by in situ hybridization to the enlarged BALT structures and parenchymal
lymphoid aggregates that characterized silicosis in these
mice. In addition, cells staining positively for IFN-
message were found mingled with macrophages, mesenchymal
cells, and debris within the silicotic alveolar lesions. These
findings appear to support our hypothesis that silicosis involves a Th-1-like lymphocyte-dominated process. The results suggest that IFN-
is produced in direct proximity to
the developing disease process, and could influence the
functions of macrophages and other cell types at those sites.
Changes in IL-4 Production
The production of IL-4 in the lungs of mice with silicosis
appeared to be unchanged or slightly downregulated compared with air-sham control animals. When assessed by
mRNA abundance, there was no change 2 wk after exposure and there was a reduction to approximately 50% at 16 wk. By flow cytometry, the percentage of cells with IL-4
peptide was not changed significantly, and the approximate absolute number would have been increased. Cells expressing IL-4 mRNA were found in the BALT tissues of
both control and silica-exposed mice, but were not observed in the silicotic lung parenchymal lesions. Thus, the
relative abundance of IL-4 compared with IFN-
appears
to be decreased in silicosis, although the absolute abundance of cells producing IL-4 may be increased compared
with control mice.
IL-4 potentiates fibroblast collagen production (25, 28-
30, 65), and may be a mechanism to promote fibrosis (31-
34). Hypothetically, IL-4 could also promote pulmonary
fibrosis in silicosis. The more prominent production of
IFN-
and relatively less abundant production of IL-4 that
we observed in mice following silica exposure suggest that
IL-4 is not a major influence on fibrosis in this disease. Measurements of cytokines are always complex, and demand reservations in their interpretation. Most cytokines
interact intensely with others to modulate the balance of
the entire cytokine network. This cross-influence is important with IFN-
and IL-4, as Th-1 and Th-2 lymphocyte
subtypes and their cytokine profiles appear to be opposite
and competitive (12). The profile of cytokines observed
at any moment in a disease process probably represents both a pathway to the disease and an attempt to restore
normal cytokine balance. Experiments that observe but do
not perturb the cytokine network cannot distinguish these
interrelated processes with confidence. Studies that intervene in the disease process to augment or reduce IFN-
and IL-4 will be needed to understand more completely
the role and importance of these cytokines in silicosis.
Cytokine Responses in Lymphoid Organs Outside of the Lung
Increased abundance of IFN-
mRNA was observed in
the intrathoracic lymphoid organs of silicotic mice. We removed the mediastinal lymph nodes and the thymus as a
single block of tissue because we were not able to separate
these structures reliably in mice. We examined these tissues to serve as an expected source of mRNA transcripts
for both IFN-
and IL-4 in case either cytokine appeared to be scarce or absent from lung samples, and to determine
whether any alterations in cytokine expression found
within the lung extended to nearby and/or draining lymphoid organs as well. The observation of increased steady-state IFN-
mRNA is consistent with our previous report
showing activation of T cells in the enlarged thoracic nodes of rats with silicosis (36).
An increased percentage of cells with intracellular IFN-
was detected by flow cytometry in the spleens of silicotic
mice. We examined spleen cells as a reliable and abundant
source of easily isolated lymphocytes for flow cytometry,
and to determine whether any alterations in cytokine regulation in silicosis extended to systemic sites beyond the
lung. The finding of upregulation of IFN-
at a lymphoid
site remote from direct silica contact and within the abdomen could help explain our previous observation that peritoneal macrophages from rats with silicosis are "primed" for increased production of TNF-
upon secondary stimulation (46).
The percentage of cells producing IL-4 was the same in
the spleens of air-sham control and silica-exposed mice after exposure. IL-4 mRNA was similar in the mediastinal
nodes/thymus tissue of both groups at 2 wk, but appeared
to be decreased substantially by 16 wk in the silica-exposed
mice. These observations suggest that the IL-4 biologic
signal appears to be decreased relative to the IFN-
signal
in both the proximate and remote lymphoid tissues of mice
with pulmonary silicosis.
| |
Conclusions |
|---|
|
|
|---|
We have found evidence for increased production of IFN-
in the lymphoid tissue and parenchymal lesions of the lungs
of mice with silicosis. The augmented IFN-
response appears to develop early, and to persist through at least 20 wk of developing disease. The increased production of
IFN-
extends to other lymphoid organs within the thorax
and at remote sites. At the same time, the production of
IL-4 appears to be unchanged or decreased. If these two
cytokines are viewed as markers and effectors of Th-1- or
Th-2-like lymphocyte-mediated immune-inflammatory responses, then silicosis would follow a Th-1-like pattern
within this paradigm. This concept is consistent with the
many observations indicating both local and indirect macrophage activation in silicosis, and with the histologic features that resemble granuloma formation. Additional research will be required to identify further the functional
phenotypes of the cells producing IFN-
, and to understand more fully the exact role of this potent cytokine in
the pathogenesis of silicosis.
| |
Footnotes |
|---|
Address correspondence to: Gerald S. Davis, M.D., Director, Pulmonary Disease & Critical Care Medicine, Given C-317, College of Medicine, University of Vermont, Burlington, VT 05405. E-mail: gdavis1{at}zoo.uvm.edu
(Received in original form April 29, 1998 and in revised form August 25, 1998).
Abbreviations: bronchoalveolar lavage fluid, BALF; bronchial-associated lymphoid tissues, BALT; base pair(s), bp; complementary DNA, cDNA; deoxyribonuclease, DNase; fetal calf serum, FCS; glyceraldehyde-3-phosphate dehydrogenase, GAPDH; interferon-
, IFN-
; immunoglobulin, Ig; interleukin, IL; messenger RNA, mRNA; optical density, OD; phosphate-buffered saline, PBS; ribonuclease, RNase; reverse transcription-polymerase chain reaction, RT-PCR; tumor necrosis factor, TNF.
Acknowledgments: This work was supported by grant RO1-HL47069 from the National Heart, Lung, and Blood Institute. The authors thank Ralph C. Budd, M.D., Julie Desbarats, Ph.D., and M. Karen Newell, Ph.D., for their suggestions regarding this manuscript; and Michael C. Miller and Collette Charland for their technical assistance.
| |
References |
|---|
|
|
|---|
1. Davis, G. S.. 1986. Pathogenesis of silicosis: current concepts and hypotheses. Lung 164: 139-154 [Medline].
2. Davis, G. S., and D. Gemsa. 1996. Immunopathogenesis of silicosis. In Immunopathology of Lung Disease, 1st ed. R. L. Kradin and B. W. S. Robinson, editors. Butterworth-Heinemann, Boston. 445-467.
3. Christman, J. W., R. J. Emerson, D. R. Hemenway, W. G. Graham, and G. S. Davis. 1991. Effects of work exposure, retirement, and smoking on bronchoalveolar lavage measurements of lung dust in Vermont granite workers. Am. Rev. Respir. Dis. 144: 1307-1313 [Medline].
4. Brody, A. R., M. W. Roe, J. N. Evans, and G. S. Davis. 1982. Deposition and translocation of inhaled silica in rats: quantification of particle distribution, macrophage participation, and function. Lab. Invest. 47: 533-542 [Medline].
5. Absher, M. P., L. Trombley, D. R. Hemenway, R. M. Mickey, and K. O. Leslie. 1989. Biphasic cellular and tissue response of rat lungs after eight-day aerosol exposure to the silicon dioxide cristobalite. Am. J. Pathol. 134: 1243-1251 [Abstract].
6.
Davis, G. S.,
K. O. Leslie,
J. E. Schwarz,
L. M. Pfeiffer,
L. Hill,
Eubanks, and
D. R. Hemenway.
1993.
Altered patterns of lung lymphocyte accumulation in silicosis in cytokine-sufficient (C3H/HeN) and cytokine-deficient
(C3H/HeJ-LPSd) mice.
Chest
103:
120S-121S
7. Sjostrand, M., P. M. Absher, D. R. Hemenway, L. Trombley, and L. C. Baldor. 1991. Comparison of lung alveolar and tissue cells in silica-induced inflammation. Am. Rev. Respir. Dis. 143: 47-52 [Medline].
8. Kumar, R. K.. 1989. Quantitative immunohistologic assessment of lymphocyte populations in the pulmonary inflammatory response to intratracheal silica. Am. J. Pathol. 135: 605-614 [Abstract].
9. Struhar, D., R. J. Harbeck, and R. J. Mason. 1989. Lymphocyte populations in lung tissue, bronchoalveolar lavage fluid, and peripheral blood in rats at various times during the development of silicosis. Am. Rev. Respir. Dis. 139: 28-32 [Medline].
10. Kumar, R. K., W. Li, and R. O'Grady. 1990. Activation of lymphocytes in the pulmonary inflammatory response to silica. Immunol. Invest. 19: 363-372 [Medline].
11. Hubbard, A. H.. 1989. Role for T lymphocytes in silica-induced pulmonary inflammation. Lab. Invest. 61: 46-52 [Medline].
12. Seder, R. A., and W. E. Paul. 1994. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu. Rev. Immunol. 12: 635-673 [Medline].
13. Garside, P., and A. M. Mowat. 1995. Polarization of Th-cell responses: a phylogenetic consequence of nonspecific immune defense? Immunol. Today 16: 220-223 [Medline].
14. Swain, S. L.. 1995. CD4 T cell development and cytokine polarization: an overview. J. Leukoc. Biol. 57: 795-798 [Abstract].
15. Farrar, M. A., and R. D. Schreiber. 1993. The molecular cell biology of interferon-gamma and its receptor. Annu. Rev. Immunol. 11: 571-611 [Medline].
16. Billiau, A.. 1996. Interferon-gamma: biology and role in pathogenesis. Adv. Immunol. 62: 61-130 [Medline].
17. Young, H. A.. 1996. Regulation of interferon-gamma gene expression. J. Interferon Cytokine Res. 16: 563-568 [Medline].
18. Chujor, C. S., L. Klein, and C. Lam. 1996. Selective inhibition of interleukin-1 beta gene expression in activated RAW 264.7 macrophages by interferon-gamma. Eur. J. Immunol. 26: 1253-1259 [Medline].
19. Prior, C., and P. L. Haslam. 1992. In vivo levels and in vitro production of interferon-gamma in fibrosing interstitial lung diseases. Clin. Exp. Immunol. 88: 280-287 [Medline].
20. Brown, M. A., and J. Hural. 1997. Functions of IL-4 and control of its expression. Crit. Rev. Immunol. 17: 1-32 [Medline].
21. Paul, W. E.. 1997. Interleukin 4: signalling mechanisms and control of T cell differentiation. Ciba Found. Symp. 204: 208-216 [Medline].
22. Puri, R. K.. 1995. Structure and function of interleukin-4 and its receptor. Cancer Treat. Res. 80: 143-185 [Medline].
23. Ryan, J. J.. 1997. Interleukin-4 and its receptor: essential mediators of the allergic response. J. Allergy Clin. Immunol. 99: 1-5 [Medline].
24. Wills-Karp, M., S. H. Gavett, B. Schofield, and F. Finkelman. 1996. Role of interleukin-4 in the development of allergic airway inflammation and airway hyperresponsiveness. Adv. Exp. Med. Biol. 409: 343-347 [Medline].
25. Fertin, C., J. F. Nicolas, P. Gillery, B. Kalis, J. Banchereau, and F. X. Maquart. 1991. Interleukin-4 stimulates collagen synthesis by normal and scleroderma fibroblasts in dermal equivalents. Cell. Mol. Biol. 37: 823-829 [Medline].
26. Gillery, P., C. Fertin, J. F. Nicolas, F. Chastang, B. Kalis, J. Banchereau, and F. X. Marquart. 1992. Interleukin-4 stimulates collagen gene expression in human fibroblast monolayer cultures: potential role in fibrosis. FEBS Lett. 302: 231-234 [Medline].
27.
Trautmann, A.,
G. Krohne,
E. B. Brocker, and
C. E. Klein.
1998.
Human
mast cells augment fibroblast proliferation by heterotypic cell-cell adhesion and action of IL-4.
J. Immunol.
160:
5053-5057
28. Lee, K. S., Y. J. Ro, Y. W. Ryoo, H. J. Kwon, and J. Y. Song. 1996. Regulation of interleukin-4 on collagen gene expression by systemic sclerosis fibroblasts in culture. J. Dermatol. Sci. 12: 110-117 [Medline].
29. Serpier, H., P. Gillery, V. Salmon-Ehr, R. Garnotel, N. Georges, B. Kalis, and F. X. Marquart. 1997. Antagonistic effects of interferon-gamma and interleukin-4 on fibroblast cultures. J. Invest. Dermatol. 109: 158-162 [Medline].
30. Postlethwaite, A. E., M. A. Holness, H. Katai, and R. Raghow. 1992. Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. J. Clin. Invest. 90: 1479-1485 .
31. Wallace, W. A., E. A. Ramage, D. Lamb, and S. E. Howie. 1995. A type 2 (Th2-like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA). Clin. Exp. Immunol. 101: 436-441 [Medline].
32.
Salmon-Ehr, V.,
H. Serpier,
B. Nawrocki,
P. Gillery,
C. Clavel,
B. Kalis, and
F. X. Marquart.
1996.
Expression of interleukin-4 in scleroderma skin specimens and scleroderma fibroblast cultures: potential role in fibrosis.
Arch.
Dermatol.
132:
802-806
33.
Buttner, C.,
A. Skupin,
T. Reimann,
E. P. Rieber,
G. Unteregger,
P. Geyer, and
K. H. Frank.
1997.
Local production of interleukin-4 during radiation-
induced pneumonitis and pulmonary fibrosis in rats: macrophages as a
prominent source of interleukin-4.
Am. J. Respir. Cell Mol. Biol.
17:
315-325
34. Sharma, S. K., J. A. MacLean, C. Pinto, and R. L. Kradin. 1996. The effect of an anti-CD3 monoclonal antibody on bleomycin-induced lymphokine production and lung injury. Am. J. Respir. Crit. Care Med. 154: 193-200 [Abstract].
35.
Huaux, F.,
J. Louahed,
B. N. Hudspith,
C. Meredith,
M. Delos,
J.-C. Renauld, and
D. Lison.
1998.
Role of interleukin-10 in the lung response
to silica in mice.
Am. J. Respir. Cell Mol. Biol.
18:
51-59
36. Davis, G. S., K. O. Leslie, and D. R. Hemenway. 1998. Silicosis in mice: effects of dose, time, and genetic strain. J. Environ. Pathol. Toxicol. Oncol. 17: 81-97 [Medline].
37. Davis, G. S., L. M. Pfeiffer, and D. R. Hemenway. 1998. Persistent over- expression of interleukin-1b and tumor necrosis factor-a in murine silicosis. J. Environ. Pathol. Toxicol. Oncol. 17: 99-114 [Medline].
38. Schmidt, J. A., C. N. Oliver, J. L. Lepe, Zuniga, I. Green, and I. Gery. 1984. Silica-stimulated monocytes release fibroblast proliferation factors identical to interleukin 1: a potential role for interleukin 1 in the pathogenesis of silicosis. J. Clin. Invest. 73: 1462-1472 .
39. Kampschmidt, R. F., M. L. Worthington III, and M. I. Mesecher. 1986. Release of interleukin-1 (IL-1) and IL-1-like factors from rabbit macrophages with silica. J. Leukoc. Biol. 39: 123-132 [Abstract].
40. Oghiso, Y., and Y. Kubota. 1987. Interleukin 1 production and accessory cell function of rat alveolar macrophages exposed to mineral dust particles. Microbiol. Immunol. 31: 275-287 [Medline].
41. Hurme, M., and I. J. Seppala. 1988. Differential induction of membrane- associated interleukin 1 (IL-1) expression and IL-1 alpha and IL-1 beta secretion by lipopolysaccharide and silica in human monocytes. Scand. J. Immunol. 27: 725-730 [Medline].
42. Struhar, D. J., R. J. Harbeck, N. Gegen, H. Kawada, and R. J. Mason. 1989. Increased expression of class II antigens of the major histocompatibility complex on alveolar macrophages and alveolar type II cells and interleukin-1 (IL-1) secretion from alveolar macrophages in an animal model of silicosis. Clin. Exp. Immunol. 77: 281-284 [Medline].
43. Struhar, D., and R. J. Harbeck. 1989. Anti-Ia antibodies inhibit the spontaneous secretion of IL-1 from silicotic rat alveolar macrophages. Immunol. Lett. 23: 31-34 [Medline].
44.
LaSalle, X..
1990.
BAL in miners: TNF
& IL-1.
Am. Rev. Respir. Dis.
141:
1-2
.
45. Dubois, C. M., E. Bissonnette, and M. Rola-Pleszczynski. 1989. Asbestos fibers and silica particles stimulate rat alveolar macrophages to release tumor necrosis factor: autoregulatory role of leukotriene B4. Am. Rev. Respir. Dis. 139: 1257-1264 [Medline].
46.
Mohr, C.,
D. Gemsa,
C. Graebner,
D. R. Hemenway,
K. O. Leslie,
P. M. Absher, and
G. S. Davis.
1991.
Systemic macrophage stimulation in rats
with silicosis: enhanced release of tumor necrosis factor-
from alveolar
and peritoneal macrophages.
Am. J. Respir. Cell Mol. Biol.
5:
395-402
.
47. Piguet, P. F., M. A. Collart, G. E. Grau, A. P. Sappino, and P. Vassalli. 1990. Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis. Nature 344: 245-247 [Medline].
48. Piguet, P. F., and C. Vesin. 1994. Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice. Eur. Respir. J. 7: 515-518 [Abstract].
49. Hemenway, D. R., and S. M. MacAskill. 1982. Design, development and test results of a horizontal flow inhalation toxicology facility. Am. Ind. Hyg. Assoc. J. 43: 874-879 [Medline].
50. Hemenway, D. R., D. Sylvester, P. N. Gale, P. Vacek, and J. N. Evans. 1983. Effectiveness of animal rotation in achieving uniform dust exposure and lung dust deposition in horizontal flow chambers. Am. Ind. Hyg. Assoc. J. 44: 655-658 [Medline].
51. Hemenway, D. R., M. P. Absher, L. Trombley, and P. M. Vacek. 1990. Comparative clearance of quartz and cristobalite from the lung. Am. Ind. Hyg. Assoc. J. 51: 363-369 [Medline].
52. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159 [Medline].
53. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, Plainview, NY.
54. An, S. F., D. Franklin, and K. A. Fleming. 1992. Generation of digoxigenin-labelled double-stranded and single-stranded probes using the polymerase chain reaction. Mol. Cell. Probes 6: 193-200 [Medline].
55.
Morey, A. L.,
H. J. Porter,
J. W. Keeling, and
K. A. Fleming.
1992.
Non-isotopic in situ hybridisation and immunophenotyping of infected cells in the
investigation of human fetal parvovirus infection.
J. Clin. Pathol.
45:
673-678
56. Fleming, K. A., M. Evans, K. C. Ryley, D. Franklin, R. H. Lovell, and A. L. Morey. 1992. Optimization of non-isotopic in situ hybridization on formalin-fixed, paraffin-embedded material using digoxigenin-labelled probes and transgenic tissues. J. Pathol. 167: 9-17 [Medline].
57. Crowell, R. E., E. Heaphy, Y. E. Valdez, C. Mold, and B. E. Lehnert. 1992. Alveolar and interstitial macrophage populations in the murine lung. Exp. Lung Res. 18: 435-446 [Medline].
58. Sebring, R. J., and B. E. Lehnert. 1992. Morphometric comparisons of rat alveolar macrophages, pulmonary interstitial macrophages, and blood monocytes. Exp. Lung Res. 18: 479-496 [Medline].
59. Lavnikova, N., S. Prokhorova, L. Helyar, and D. L. Laskin. 1993. Isolation and partial characterization of subpopulations of alveolar macrophages, granulocytes, and highly enriched interstitial macrophages from rat lung. Am. J. Respir. Cell Mol. Biol. 8: 384-392 .
60. Rogers, R. A., D. R. Tasat, A. E. Warner, and J. D. Brain. 1994. Quantitative recovery of pulmonary intravascular macrophages from sheep lungs. J. Leukoc. Biol. 56: 692-701 [Abstract].
61.
Picker, L. J.,
M. K. Singh,
Z. Zdraveski,
J. R. Treer,
S. L. Waldrop,
P. R. Bergstresser, and
V. C. Maino.
1995.
Direct demonstration of cytokine
synthesis heterogeneity among human memory/effector T cells by flow cytometry.
Blood
86:
1408-1419
62. Ferrick, D. A., M. D. Schrenzel, T. Mulvania, B. Hsieh, W. G. Ferlin, and H. Lepper. 1995. Differential production of interferon-gamma and interleukin-4 in response to Th1- and Th2-stimulating pathogens by gamma delta T cells in vivo. Nature 373: 255-257 [Medline].
63. Jung, T., U. Schauer, C. Heusser, C. Neumann, and C. Rieger. 1993. Detection of intracellular cytokines by flow cytometry. J. Immunol. Methods 159: 197-207 [Medline].
64. Assenmacher, M., J. Schmitz, and A. Radbruch. 1994. Flow cytometric determination of cytokines in activated murine T helper lymphocytes: expression of interleukin-10 in interferon-gamma and in interleukin-4- expressing cells. Eur. J. Immunol. 24: 1097-1101 [Medline].
65. Sempowski, G. D., S. Derdak, and R. P. Phipps. 1996. Interleukin-4 and interferon-gamma discordantly regulate collagen biosynthesis by functionally distinct lung fibroblast subsets. J. Cell. Physiol. 167: 290-296 [Medline].
This article has been cited by other articles:
![]() |
R. Pasula, B. E. Britigan, J. Turner, and W. J. Martin II Airway Delivery of Silica Increases Susceptibility to Mycobacterial Infection in Mice: Potential Role of Repopulating Macrophages J. Immunol., June 1, 2009; 182(11): 7102 - 7109. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. Migliaccio, M. C. Buford, F. Jessop, and A. Holian The IL-4R{alpha} pathway in macrophages and its potential role in silica-induced pulmonary fibrosis J. Leukoc. Biol., March 1, 2008; 83(3): 630 - 639. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Misson, F. Brombacher, M. Delos, D. Lison, and F. Huaux Type 2 immune response associated with silicosis is not instrumental in the development of the disease Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L107 - L113. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Yun, P. Y. Lee, and A. N. Gerber Integrating systems biology and medical imaging: understanding disease distribution in the lung model. Am. J. Roentgenol., April 1, 2006; 186(4): 925 - 930. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Barbarin, Z. Xing, M. Delos, D. Lison, and F. Huaux Pulmonary overexpression of IL-10 augments lung fibrosis and Th2 responses induced by silica particles Am J Physiol Lung Cell Mol Physiol, May 1, 2005; 288(5): L841 - L848. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Misson, S. van den Brule, V. Barbarin, D. Lison, and F. Huaux Markers of macrophage differentiation in experimental silicosis J. Leukoc. Biol., November 1, 2004; 76(5): 926 - 932. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Barbarin, M. Arras, P. Misson, M. Delos, B. McGarry, S. H. Phan, D. Lison, and F. Huaux Characterization of the Effect of Interleukin-10 on Silica-Induced Lung Fibrosis in Mice Am. J. Respir. Cell Mol. Biol., July 1, 2004; 31(1): 78 - 85. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Chen, B. M. Greenlee, M. Wills-Karp, and D. R. Moller Attenuation of Lung Inflammation and Fibrosis in Interferon-{gamma}-Deficient Mice after Intratracheal Bleomycin Am. J. Respir. Cell Mol. Biol., May 1, 2001; 24(5): 545 - 555. [Abstract] [Full Text] |
||||
![]() |
M. Arras, F. Huaux, A. Vink, M. Delos, J.-P. Coutelier, M.-C. Many, V. Barbarin, J.-C. Renauld, and D. Lison Interleukin-9 Reduces Lung Fibrosis and Type 2 Immune Polarization Induced by Silica Particles in a Murine Model Am. J. Respir. Cell Mol. Biol., April 1, 2001; 24(4): 368 - 375. [Abstract] [Full Text] |
||||
![]() |
Z. Wang, T. Zheng, Z. Zhu, R. J. Homer, R. J. Riese, H. A. Chapman Jr., S. D. Shapiro, and J. A. Elias Interferon {gamma} Induction of Pulmonary Emphysema in the Adult Murine Lung J. Exp. Med., December 4, 2000; 192(11): 1587 - 1600. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Garn, A. Friedetzky, A. Kirchner, R. Jager, and D. Gemsa Experimental silicosis: a shift to a preferential IFN-gamma -based Th1 response in thoracic lymph nodes Am J Physiol Lung Cell Mol Physiol, June 1, 2000; 278(6): L1221 - L1230. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Davis, L. M. Pfeiffer, and D. R. Hemenway Interferon-gamma Production by Specific Lung Lymphocyte Phenotypes in Silicosis in Mice Am. J. Respir. Cell Mol. Biol., April 1, 2000; 22(4): 491 - 501. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Crit. Care Med. |